Advertisement
U.S. markets closed
Advertisement

Femasys Inc. (FEMY)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
0.8820-0.0108 (-1.21%)
At close: 04:00PM EST
0.9097 +0.03 (+3.14%)
After hours: 05:33PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Hammer

Hammer

Performance Outlook
Previous Close0.8928
Open0.9018
Bid0.8800 x 900
Ask0.9200 x 3000
Day's Range0.8720 - 0.9018
52 Week Range0.2480 - 4.7500
Volume345,744
Avg. Volume10,506,031
Market Cap19.095M
Beta (5Y Monthly)-3.70
PE Ratio (TTM)N/A
EPS (TTM)-0.9800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FEMY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Femasys Inc.
    Daily – Vickers Top Buyers & Sellers for 06/28/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • GlobeNewswire

    Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

    -- Thought leader from top-ranked academic gynecology program to lead clinical and medical affairs at Femasys --ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the appointment of James Liu, M.D., as Chief Medi

  • Insider Monkey

    30 Countries with the Lowest Median Age in the World

    In this article, we will be analyzing the age structures globally while covering the 30 countries with the lowest median age in the world. If you wish to skip our detailed analysis, you can move directly to the 5 Countries with the Lowest Median Age in the World. Age Dynamics Around the World While the […]

  • GlobeNewswire

    Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

    - Topline results from FemaSeed® pivotal trial expected in 1H 2024 - - Commercial launch planned for early 2024 - ATLANTA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced completion of enrollment in the LOCAL FemaSeed®